<DOC>
	<DOCNO>NCT00321802</DOCNO>
	<brief_summary>The purpose study determine effect statin therapy prevention atrial fibrillation ( AF ) pacemaker non-pacemaker patient paroxysmal atrial fibrillation absence significant coronary artery disease .</brief_summary>
	<brief_title>Paroxysmal Atrial Fibrillation : Role Inflammation , Oxidative Stress Injury Effect Statins</brief_title>
	<detailed_description>Patients history paroxysmal atrial fibrillation , without dual chamber pacemaker meet study criterion , randomize receive either placebo , simvastatin 40 mg , daily 6 month . Liver enzymes draw randomization 3 month . CRP oxidative stress product draw randomization , weekly first month monthly 5 month . Patients transmit rhythm , twice daily 5 consecutive day randomization , 5 consecutive day monthly 6 month . Clinic visit require randomization , 3 month 6 month .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients paroxysmal AF ( &gt; 3 epi &gt; 15 min length ) 6 month Patients stable antiarrhythmic drug therapy life expectancy &gt; 1 year Patients PAF due reversible cause Chronic inflammatory condition Other medical condition require statin therapy Patients amiodarone verapamil Elevated CK ALT Life expectancy &lt; 1 year TAVN ablation Geographic isolation Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>statin therapy</keyword>
	<keyword>CRP level</keyword>
	<keyword>Paroxysmal Atrial Fibrillation</keyword>
</DOC>